North Star Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

North Star Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60	Closed	-$746	–	1737
2026 Q1	$746	Hold	60	–	–	﹤0.01%	1534
2025 Q4	$756	Hold	60	–	–	﹤0.01%	1420
2025 Q3	$601	Hold	60	–	–	﹤0.01%	1210
2025 Q2	$485	Hold	60	–	–	﹤0.01%	1160
2025 Q1	$503	Hold	60	–	–	﹤0.01%	1144
2024 Q4	$475	Hold	60	–	–	﹤0.01%	1172
2024 Q3	$499	Hold	60	–	–	﹤0.01%	1132
2024 Q2	$381	Hold	60	–	–	﹤0.01%	1114
2024 Q1	$364	Hold	60	–	–	﹤0.01%	1186
2023 Q4	$364	Hold	60	–	–	﹤0.01%	1148
2023 Q3	$253	Hold	60	–	–	﹤0.01%	1236
2023 Q2	$186	Hold	60	–	–	﹤0.01%	1253
2023 Q1	$83	Hold	60	–	–	﹤0.01%	1284
2022 Q4	$119	Hold	60	–	–	﹤0.01%	1289
2022 Q3	$0	Hold	60	–	–	﹤0.01%	1131
2022 Q2	$0	Hold	60	–	–	﹤0.01%	1131
2022 Q1	$0	Hold	60	–	–	﹤0.01%	1145
2021 Q4	$0	Sell	60 -300	-83%	-$1.5K	﹤0.01%	1173
2021 Q3	$2K	Buy	360 +300	+500%	+$1.51K	﹤0.01%	1022
2021 Q2	$0	Hold	60	–	–	﹤0.01%	1093
2021 Q1	$0	Hold	60	–	–	﹤0.01%	1053
2020 Q4	$0	Hold	60	–	–	﹤0.01%	1020
2020 Q3	$0	Hold	60	–	–	﹤0.01%	1000
2020 Q2	$0	Hold	60	–	–	﹤0.01%	971
2020 Q1	$0	Hold	60	–	–	﹤0.01%	995
2019 Q4	$0	Hold	60	–	–	﹤0.01%	1038
2019 Q3	$0	Buy	+60	New	+$209	﹤0.01%	1088

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

North Star Investment Management's AMRX Position: Q2 2026 in Review

North Star Investment Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 60 shares — an estimated $746 sold.

North Star Investment Management first reported a position in AMRX in Q3 2019 and held it in 27 quarters. The position peaked at $2K in Q3 2021. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

North Star Investment Management reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
North Star Investment Management sold 60 Amneal Pharmaceuticals shares in Q2 2026, an estimated $746.
North Star Investment Management first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 27 quarters.
North Star Investment Management's Amneal Pharmaceuticals position peaked at $2K in Q3 2021.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.